Treatment of Apathy Syndrome
Treatment of Apathy Syndrome After Acquired Brain Injury – A Case Series
Ravi Kant, MD
Abstract:
Apathy syndrome is a significant clinical problem in patients with neuropsychiatric sequalae after acquired brain injury (ABI). It may coexist with depression and impact the clinical picture and treatment outcomes. Results of treatment of apathy syndrome in this small sample of patients (N=19) with ABI are presented. Dopaminergic agonists were used for treatment and the response was measured with Apathy Evaluation Scale (AES) and Beck Depression Inventory (BDI). All of the 19 patients responded to treatment and improvement in apathy scores was statistically significant (p.004) and no significant change was noted in depression (p.22). (submitted for publication]
Apathy syndrome is a significant clinical problem in patients with neuropsychiatric sequalae after acquired brain injury (ABI). It may coexist with depression and impact the clinical picture and treatment outcomes. Results of treatment of apathy syndrome in this small sample of patients (N=19) with ABI are presented. Dopaminergic agonists were used for treatment and the response was measured with Apathy Evaluation Scale (AES) and Beck Depression Inventory (BDI). All of the 19 patients responded to treatment and improvement in apathy scores was statistically significant (p.004) and no significant change was noted in depression (p.22). (submitted for publication]